Subject(s)
Cytomegalovirus Infections/virology , Psoriasis/virology , Antigens, Viral/blood , Combined Modality Therapy , Cytomegalovirus/immunology , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/diagnosis , Cytomegalovirus Infections/therapy , Glucocorticoids/therapeutic use , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Male , Middle Aged , Neutrophils/virology , Phosphoproteins/blood , Prednisolone/therapeutic use , Psoriasis/diagnosis , Psoriasis/therapy , Ultraviolet Therapy , Viral Matrix Proteins/blood , Young AdultSubject(s)
Angiogenesis Inhibitors/adverse effects , Antibodies, Monoclonal/adverse effects , Foot Dermatoses/chemically induced , Hand Dermatoses/chemically induced , Aged , Antibodies, Monoclonal, Humanized , Bevacizumab , Blister/chemically induced , Erythema/chemically induced , Female , Foot Dermatoses/pathology , Hand Dermatoses/pathology , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Overexpression of vascular endothelial growth factor (VEGF) in epidermal lesions of psoriasis is well documented; however, its underlying mechanisms are largely unknown. We have recently demonstrated that vasoactive intestinal peptide (VIP) induces the production of cytokines such as interleukin-6 and stem cell factor from keratinocytes, thereby contributing to the development of inflammatory dermatoses such as psoriasis. OBJECTIVES: In this study, we attempted to determine whether VIP could increase the production of VEGF in human keratinocytes. METHODS: We examined the expression of VEGF using reverse transcription-polymerase chain reaction, immunocytochemistry, enzyme-linked immunosorbent assay and immunoblotting in normal human epidermal keratinocytes and human epidermal keratinocyte cell line DJM-1 cultured in the absence or presence of VIP and/or inflammatory cytokines. RESULTS: We demonstrate that human keratinocytes produced VEGF in a steady state at both mRNA and protein levels. VIP significantly upregulated the production of VEGF in keratinocytes in a dose- and time-dependent manner. The VIP-mediated production of VEGF was further enhanced by inflammatory cytokines such as interferon-gamma, tumour necrosis factor-alpha and interleukin-4, with maximum enhancement being observed with the combination of VIP and interferon-gamma. CONCLUSIONS: VIP and other cytokines from nerve endings, mast cells and local inflammatory cells are capable of enhancing VEGF production from epidermal keratinocytes, which may underlie excessive angiogenesis and vasodilation in skin lesions of psoriasis.